# CAR-T Cell Immunotherapy for Advanced Lung Cancer

> **NCT03330834** · PHASE1 · TERMINATED · sponsor: **Sun Yat-sen University** · enrollment: 1 (actual)

## Conditions studied

- Advanced Lung Cancer

## Interventions

- **BIOLOGICAL:** CAR-T cells to treat advanced lung cancer

## Key facts

- **NCT ID:** NCT03330834
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-20
- **Primary completion:** 2020-04-14
- **Final completion:** 2020-04-14
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Serious adverse events
- **Last updated:** 2020-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03330834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03330834, "CAR-T Cell Immunotherapy for Advanced Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03330834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*